Download PDF
Planta Med 2015; 81(12/13): 1038-1044
DOI: 10.1055/s-0035-1546129
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Trans-Resveratrol Induces Apoptosis through ROS-Triggered Mitochondria-Dependent Pathways in A549 Human Lung Adenocarcinoma Epithelial Cells[*]

Ina Katharina Lucas
Freie Universität Berlin, Institute of Pharmacy, Pharmaceutical Biology, Berlin, Germany
,
Herbert Kolodziej
Freie Universität Berlin, Institute of Pharmacy, Pharmaceutical Biology, Berlin, Germany
› Author Affiliations
Further Information

Publication History

received 11 February 2015
revised 21 April 2015

accepted 23 April 2015

Publication Date:
17 June 2015 (online)

    Permissions and Reprints

Abstract

Resveratrol has been shown to be a potential chemopreventive and anticancer agent, inducing apoptosis in a variety of cancer cells. The present study was performed to evaluate the effect of resveratrol on A549 human lung adenocarcinoma epithelial cells. 3-(4,5-Dimethylthiazol-2-Yl)-2,5-diphenyltetrazolium bromide evaluation demonstrated that the exposure of cells to increasing concentrations of resveratrol (0–175 µM) for 24 h resulted in a decrease in cell viability (IC50 85.5 µM). Annexin V/propidium iodide double stain verified apoptosis in A549 cells, while negligible cell cytotoxity (≥ 0.5 %) was observed in all untreated incubations. Using colorimetric assay kits, induction of caspase-3, but not of caspase-8, activity was detected in response to resveratrol (> 130 µM). Confirmatory evidence of this finding was provided by Western blotting, indicating expression of cleaved caspase-3 levels in a concentration-dependent manner with a minimum resveratrol concentration of 65 µM required for activation of this protease, while that of caspase-8 remained unaffected. The apoptotic process was associated with reactive oxygen species production in a concentration-dependent manner, evidenced by microscopic examination and fluorescence-activated cell sorting analysis using the 2′,7′-dichlorofluorescein diacetate assay. In the presence of the mitochondrial electron transport chain inhibitor rotenone, reactive oxygen species production and the concomitant apoptotic cell population were significantly reduced. This finding suggested that the resveratrol-induced apoptosis was mediated via a mitochondrial pathway alignment in human A549 cells. Although effective levels were observed at high concentrations, the outcome may well differ under in vivo conditions. Finally, experiments reaffirmed the chemical instability of trans-resveratrol, suggesting the need for protection of the solutions from extended exposure to light.

Key words

resveratrol - A549 cells - cytotoxicity - apoptosis - caspases - ROS

* Dedicated to Professor Dr. Dr. h. c. mult. Adolf Nahrstedt on the occasion of his 75th birthday.


Supporting Information

 

  • References

  • 1 Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo evidence. Nature Rev 2006; 5: 493-506
    PubMedGoogle Scholar
  • 2 Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL. Resveratrol: a review of preclkinical studies for human cancer prevention. Toxicol Appl Pharmacol 2007; 224: 274-283
    CrossrefPubMedGoogle Scholar
  • 3 Vang O, Ahmad N, Baile CA, Baur JA, Brown K. What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS One 2011; 6: 1-11
    PubMedGoogle Scholar
  • 4 Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 2004; 24: 2783-2840
    PubMedGoogle Scholar
  • 5 Lancon A, Kaminski J, Tili E, Michaille JJ, Latruffe N. Control of microRNA expression as a new way for resveratrol to deliver its beneficial effects. J Agric Food Chem 2012; 60: 8783-8789
    CrossrefPubMedGoogle Scholar
  • 6 Brown VA, Patel KR, Viskaduraki M, Crowell JA, Perloff M, Booth TD, Vasilinin G, Sen A, Schinas AM, Piccirilli G, Brown K, Steward WP, Gescher AJ, Brenner DE. Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis. Cancer Res 2010; 70: 9003-9011
    CrossrefPubMedGoogle Scholar
  • 7 Patel KR, Brown VA, Jones DJ, Britton RG, Hemingway D, Miller AS, West KP, Booth TD, Perloff M, Crowell JA, Brenner DE, Steward WP, Gescher AJ, Brown K. Clinical pharmacology of resveratrol and its metabolites in colorectal cancer patients. Cancer Res 2010; 70: 7392-7399
    CrossrefPubMedGoogle Scholar
  • 8 Howells LM, Berry DP, Elliott PJ, Jacobsen EW, Hoffmann E, Hegarty B, Brown K, Steward WP, Gescher AJ. Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases–safety, pharmacokinetics, and pharmacodynamics. Cancer Prev Res (Phila) 2011; 4: 1419-1425
    CrossrefPubMedGoogle Scholar
  • 9 Patel KR, Scott E, Brown VA, Gescher AJ, Steward WP, Brown K. Clinical trials of resveratrol. Ann N Y Acad Sci 2011; 1215: 161-169
    CrossrefPubMedGoogle Scholar
  • 10 Whyte L, Huang Y, Torres K, Mehta RG. Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res 2007; 67: 12007-12017
    CrossrefPubMedGoogle Scholar
  • 11 Zhang W, Wang X, Chen T. Resveratrol induces apoptosis via a Bak-mediated intrinsic pathway in human lung adenocarcinoma cells. Cell Signal 2012; 24: 1037-1046
    CrossrefPubMedGoogle Scholar
  • 12 Luo H, Yang A, Schulte BA, Wargovich MJ, Wang GY. Resveratrol induces premature senescence in lung cancer cells via ROS-mediated DNA damage. PLoS One 2013; 8: e60065
    CrossrefPubMedGoogle Scholar
  • 13 Zhang J, Ma K, Qi T, Wei X, Zhang Q, Li G, Chiu J. P62 regulates resveratrol-mediated Fas/Cav-1 complex formation and transition from autophagy to apoptosis. Oncotarget 2015; 6: 789-801
    CrossrefPubMedGoogle Scholar
  • 14 Yuan L, Zhang Y, Xia J, Liu B, Zhang Q, Liu J, Luo L, Peng Z, Song Z, Zhu R. Resveratrol inducers cell cycle arrest via a p 53-independent pathway in A549 cells. Mol Med Rep 2015; 11: 2459-2464
    PubMedGoogle Scholar
  • 15 Gu S, Chen C, Jiang X, Zhang Z. Resveratrol synergistically triggers apoptotic cell death with arsenic trioxide via oxidative stress in human lung adenocarcinoma A549 cells. Biol Trace Elem Res 2015; 163: 112-123
    CrossrefPubMedGoogle Scholar
  • 16 Juan ME, Wenzel U, Daniel H, Planas JM. Resveratrol induces apoptosis through ROS-dependent mitochondria pathway in HT-29 human colorectal carcinoma cell. J Agric Food Chem 2008; 56: 4813-4818
    CrossrefPubMedGoogle Scholar
  • 17 Shao J, Li X, Lu X, Jiang C, Hu Y, Li Q, You Y, Fu Z. Enhanced growth inhibition effect of resveratrol incorporated into biodegradable nanoparticles against glioma cells is mediated by the induction of intracellular reactive oxygen species levels. Colloids Surf B Biointerfaces 2009; 72: 40-47
    CrossrefPubMedGoogle Scholar
  • 18 Miki H, Uehara N, Kimura A, Sasaki T, Yuri T, Yoshizawa K, Tsubura A. Resveratrol induces apoptosis via ROS-triggered autophagy in human colon cancer cells. Int J Oncol 2012; 40: 1020-1028
    PubMedGoogle Scholar
  • 19 Trela B, Waterhouse A. Resveratrol: isomeric molar absorptivities and stability. J Agric Food Chem 1996; 44: 1253-1257
    CrossrefPubMedGoogle Scholar
  • 20 Montsko G, Nikfardjam MSP, Szabo Z, Boddi K, Lorand T, Ohmacht R, Mark L. Determination of products derived from trans-resveratrol UV photoisomerisation by means of HPLC–APCI-MS. J Photochem Photobiol A 2008; 196: 44-50
    CrossrefPubMedGoogle Scholar
  • 21 Yu C, Shin YG, Chow A, Li Y, Kosmeder JW, Lee YS, Hirschelman WH, Pezzuto JM, Mehta RG, van Breemen RB. Human, rat, and mouse metabolism of resveratrol. Pharm Res 2002; 19: 1907-1914
    CrossrefPubMedGoogle Scholar
  • 22 Liu B, Xu K, Han H, Wang T, Song Y. Effect of resveratrol on apoptosis of lung adenocarcinoma cell line A549. Zhonghua Zhongliu Fangzhi Zazhi 2014; 21: 740-743
    PubMedGoogle Scholar
  • 23 Liu PL, Tsai JR, Charles AL, Hwang JJ, Cou SH, Ping YH, Lin FY, Chen YL, Hung CY, Chen WC, Chen YH, Chong IW. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-κB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol Nutr Food Res 2010; 54 (Suppl. 02) S196-S204
    CrossrefPubMedGoogle Scholar
  • 24 Chen J, Lv J, Shu Y. Effects of resveratrol on cell cycle regulatory processes of human lung adenocarcinoma A549 cells and its mechanism. Linchuang Zhongliuxue Zazhi 2011; 16: 506-509
    PubMedGoogle Scholar
  • 25 Yin HT, Tian QZ, Guan L, Zhou Y, Huang XE, Zhang H. In vitro and in vivo evaluation of the antitumor efficiency of resveratrol against lung cancer. Asian Pac J Cancer Prev 2013; 14: 1703-1706
    CrossrefPubMedGoogle Scholar
  • 26 Huang C, Ma W, Goranson A, Dong Z. Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 1999; 20: 237-242
    CrossrefPubMedGoogle Scholar
  • 27 Lucas IK, Kolodziej H. In vitro antileishmanial activity of resveratrol originates from its cytotoxic potential against host cells. Planta Med 2013; 79: 20-26
    Article in Thieme ConnectPubMedGoogle Scholar
  • 28 Low ICC, Chen ZY, Pervaiz S. Bcl-2 modulates resveratrol-induced ROS production by regulating mitochondrial respiration in tumor cells. Antioxid Redox Signal 2010; 13: 807-819
    CrossrefPubMedGoogle Scholar
  • 29 Gokbulut AA, Apohan E, Baran Y. Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest. Hematology 2013; 18: 144-150
    CrossrefPubMedGoogle Scholar
  • 30 Ewald JA, Desotelle JA, Wilding G, Jaarrard DF. Therapy-induced senescence in cancer. J Natl Cancer Inst 2010; 102: 1536-1546
    CrossrefPubMedGoogle Scholar
  • 31 Shankar S, Siddiqui I. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Mol Cell Biochem 2007; 304: 273-285
    CrossrefPubMedGoogle Scholar
  • 32 Hussain AR, Uddin S, Bu R, Khan OS, Ahmed SO, Ahmed M, Al-Kuraya KS. Resveratrol suppresses constitutive activation of AKT via generation of ROS and induces apoptosis in diffuse large B cell lymphoma cell lines. PLoS One 2011; 6: e24703
    CrossrefPubMedGoogle Scholar
  • 33 Salganik RI. The benefits and hazards of antioxidants: controlling apoptosis and other protective mechanisms in cancer patients and the human population. J Am Coll Nutr 2001; 20 (Suppl. 05) 464S-472S
    CrossrefPubMedGoogle Scholar
  • 34 Seifried HE, Anderson DE, Fisher EI, Milner JA. A review of the interaction among dietary antioxidants and reactive oxygen species. J Nutr Biochem 2007; 18: 567-579
    CrossrefPubMedGoogle Scholar
  • 35 Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol 2014; 24: R453-R462
    CrossrefPubMedGoogle Scholar
  • 36 Ye Z, Zhang J, Townsend DM, Tew KD. Oxidative stress, redox regulation and diseases of cellular differentiation. Biochim Biophys Acta 2015; 1850: 1607-1621
    CrossrefPubMedGoogle Scholar
  • 37 De Roos B, Duthie GG. Role of dietary pro-oxidants in the maintenance of health and resilience to oxidative stress. Mol Nutr Food Res DOI: 10.1002/mnfr.201400568. advance online publication 22 January 2015
    PubMedGoogle Scholar
  • 38 Colin DJ, Limagne E, Ragot K, Lizard G, Ghiringhelli F, Solary E, Chauffert B, Latruffe N, Delmas D. The role of reactive oxygen species and subsequent DNA-damage response in the emergence of resistance towards resveratrol in colon cancer models. Cell Death Dis 2014; 5: e1533
    CrossrefPubMedGoogle Scholar
  • 39 Hadi SM, Ullah MF, Shamim U, Hanf SS, Azmi AS, Bhat SH. A prooxidant mechanism of red wine polyphenols in chemoprevention of cancers. In: OʼByrne P, editor Red wine and health. New York: Nova Science Publishers Inc.; 2009: 373-388
    Google Scholar
  • 40 Azmi AS, Hadi S, Mohammad RM. Prooxidant anti-cancer mechanisms of resveratrol: An evolving yet underappreciated phenomenon. 3rd International Conference of Resveratrol and Health, Waikoloa, HI. 2014
    PubMedGoogle Scholar
  • 41 Mukherjee S, Dudley JI, Das DK. Dose-dependency of resveratrol in providing health benefits. Dose Response 2010; 8: 478-500
    CrossrefPubMedGoogle Scholar
  • 42 Singh CK, Ndiaye MA, Ahmad N. Resveratrol and cancer: Challenges for clinical translation. Biochim Biophys Acta 2015; 1852: 1178-1185
    CrossrefPubMedGoogle Scholar
  • 43 Scott E, Steard WP, Gescher AJ, Brown K. Resveratrol in human cancer chemoprecention – choosing the ‘right’ dose. Mol Nutr Food Res 2012; 56: 7-13
    CrossrefPubMedGoogle Scholar
  • 44 Mosman TJ. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxic assays. J Immunol Methods 1983; 65: 55-63
    CrossrefPubMedGoogle Scholar